1-20 of 110 Search Results for

*

Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases

Jian Ye, Weihua Guo, Chongkai Wang, Colt A Egelston, Massimo D'Apuzzo, Geereesh Shankar, Marwan G Fakih, Peter P Lee
Journal: Cancer Research Communications
Cancer Research Communications (2023)
https://doi.org/10.1158/2767-9764.CRC-23-0212
Published: 27 September 2023
View article titled, Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases
Open the PDF for Peritumoral immune suppressive mechanisms impede intratumoral lymphocyte infiltration into CRC liver versus lung metastases in another window
Includes: Supplementary data
Journal Articles

Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma

Mir Lim, Maishara Muquith, Bernadette Miramontes, Magdalena Espinoza, David Hsiehchen
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (9): 1912–1916.
https://doi.org/10.1158/2767-9764.CRC-23-0025
Published: 21 September 2023
View article titled, Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma
Open the PDF for Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma in another window
Journal Articles

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

Jesus Amo-Aparicio, Adrian Dominguez, Shaikh M. Atif, Alberto Dinarello, Tania Azam, Kibrom M. Alula, Miles Piper, Christopher H. Lieu, Robert W. Lentz, Alexis D. Leal, Stacey M. Bagby, Wells A. Messersmith, Sana D. Karam, Charles A. Dinarello, Todd M. Pitts, Carlo Marchetti
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (9): 1899–1911.
https://doi.org/10.1158/2767-9764.CRC-23-0065
Published: 20 September 2023
View article titled, Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
Open the PDF for Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment in another window
Includes: Supplementary data
Journal Articles

Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy

Richard W. Davis, IV, Astero Klampatsa, Gwendolyn M. Cramer, Michele M. Kim, Joann M. Miller, Min Yuan, Cassandra Houser, Emma Snyder, Mary Putt, Sergei A. Vinogradov, Steven M. Albelda, Keith A. Cengel, Theresa M. Busch
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (9): 1810–1822.
https://doi.org/10.1158/2767-9764.CRC-22-0494
Published: 11 September 2023
View article titled, Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
Open the PDF for Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy in another window
Includes: Supplementary data
Journal Articles

Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy

Kyle M. Garland, Alexander J. Kwiatkowski, John T. Tossberg, Philip S. Crooke, III, Thomas M. Aune, John T. Wilson
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (9): 1800–1809.
https://doi.org/10.1158/2767-9764.CRC-22-0354
Published: 08 September 2023
View article titled, Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy
Open the PDF for Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation

Valerie P. O'Brien, Yuqi Kang, Meera K. Shenoy, Greg Finak, William C. Young, Julien Dubrulle, Lisa Koch, Armando E. Rodriguez Martinez, Jeffery Williams, Elizabeth Donato, Surinder K. Batra, Cecilia C.S. Yeung, William M. Grady, Meghan A. Koch, Raphael Gottardo, Nina R. Salama
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (9): 1756–1769.
https://doi.org/10.1158/2767-9764.CRC-23-0142
Published: 05 September 2023
View article titled, Single-cell Profiling Uncovers a <em>Muc4</em>-Expressing Metaplastic Gastric Cell Type Sustained by <em>Helicobacter pylori</em>-driven Inflammation
Open the PDF for Single-cell Profiling Uncovers a <em>Muc4</em>-Expressing Metaplastic Gastric Cell Type Sustained by <em>Helicobacter pylori</em>-driven Inflammation in another window
Includes: Supplementary data
Journal Articles

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1628–1637.
https://doi.org/10.1158/2767-9764.CRC-23-0145
Published: 23 August 2023
View article titled, A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
Open the PDF for A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma

Kanika Jain, Ian C. Henrich, Laura Quick, Robert Young, Shreya Mondal, Andre M. Oliveira, Gerd A. Blobel, Margaret M. Chou
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1615–1627.
https://doi.org/10.1158/2767-9764.CRC-22-0505
Published: 22 August 2023
View article titled, Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma
Open the PDF for Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade

Sapna Yadavilli, Jeremy D. Waight, Sara Brett, Meixia Bi, Tianqian Zhang, Yao-Bin Liu, Catherine Ellis, David C. Turner, Ashleigh Hahn, Hong Shi, Laura Seestaller-Wehr, Junping Jing, Qing Xie, Jafar Sadik Shaik, Xiao Ji, Robert Gagnon, William Fieles, Laura Hook, Steven Grant, Stephanie Hopley, M. Phillip DeYoung, Christina Blackwell, Michael Chisamore, Robert Biddlecombe, David J. Figueroa, Christopher B. Hopson, Roopa Srinivasan, James Smothers, Michele Maio, Danny Rischin, Daniel Olive, Elaine Paul, Patrick A. Mayes, Axel Hoos, Marc Ballas
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1564–1579.
https://doi.org/10.1158/2767-9764.CRC-22-0293
Published: 16 August 2023
View article titled, Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Open the PDF for Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade in another window
Includes: Multimedia, Supplementary data
Journal Articles

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis, Panagiota Economopoulou, Ioannis Kotsantis, Maria Gkotzamanidou, Maria Anastasiou, Dimitrios Pectasides, Efthymios Kyrodimos, Alexander Delides, Evangelos Giotakis, Nikolaos G. Papadimitriou, Ioannis G. Panayiotides, Christos Perisanidis, Aileen I. Fernandez, Vasiliki Xirou, Christos Poulios, Eleni Gagari, Vesal Yaghoobi, Niki Gavrielatou, Saba Shafi, Thazin Nwe Aung, Andromachi Kougioumtzopoulou, Vassilis Kouloulias, Konstantinos Palialexis, Stavros Gkolfinopoulos, Areti Strati, Evi Lianidou, George Fountzilas, David L. Rimm, Periklis G. Foukas, Amanda Psyrri
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1514–1523.
https://doi.org/10.1158/2767-9764.CRC-23-0051
Published: 10 August 2023
View article titled, Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
Open the PDF for Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids

Oliver J. Pickles, Kasun Wanigasooriya, Anetta Ptasinska, Akshay J. Patel, Helen L. Robbins, Claire Bryer, Celina M. Whalley, Louise Tee, Neeraj Lal, Claudia M.A. Pinna, Nahla Elzefzafy, Philippe Taniere, Andrew D. Beggs, Gary M. Middleton
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1501–1513.
https://doi.org/10.1158/2767-9764.CRC-23-0091
Published: 09 August 2023
View article titled, MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids
Open the PDF for MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids in another window
Includes: Supplementary data
Journal Articles

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

Brian J. Francica, Anja Holtz, Justine Lopez, David Freund, Austin Chen, Dingzhi Wang, David Powell, Franciele Kipper, Dipak Panigrahy, Raymond N. Dubois, Chan C. Whiting, Peppi Prasit, Thomas W. Dubensky
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1486–1500.
https://doi.org/10.1158/2767-9764.CRC-23-0249
Published: 08 August 2023
View article titled, Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
Open the PDF for Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors in another window
Includes: Supplementary data
Journal Articles

Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jingting Jiang, Penelope A. Morel, Ziyang Zhong, Binfeng Lu
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1460–1472.
https://doi.org/10.1158/2767-9764.CRC-23-0012
Published: 04 August 2023
View article titled, Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment
Open the PDF for Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression

Cara C. Schafer, Jiji Jiang, Sally Elsamanoudi, Darryl Nousome, Denise Y. Young, Yingjie Song, Isabell A. Sesterhenn, Gregory T. Chesnut, Shyh-Han Tan
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (8): 1423–1434.
https://doi.org/10.1158/2767-9764.CRC-22-0463
Published: 01 August 2023
View article titled, Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression
Open the PDF for Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression in another window
Includes: Supplementary data
Journal Articles

Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities

Ian Ganly, Fengshen Kuo, Vladimir Makarov, Yiyu Dong, Ronald Ghossein, Bin Xu, Luc G.T. Morris, Timothy A. Chan
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1409–1422.
https://doi.org/10.1158/2767-9764.CRC-23-0120
Published: 31 July 2023
View article titled, Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities
Open the PDF for Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities in another window
Includes: Supplementary data
Journal Articles

Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion

Yasunari Fukuda, Sun-Hee Kim, Matias A. Bustos, Sung-Nam Cho, Jason Roszik, Jared K. Burks, Hong Kim, Dave S.B. Hoon, Elizabeth A. Grimm, Suhendan Ekmekcioglu
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1397–1408.
https://doi.org/10.1158/2767-9764.CRC-23-0210
Published: 31 July 2023
View article titled, Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
Open the PDF for Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion in another window
Includes: Supplementary data
Journal Articles

Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit

Benjamin J. Bulen, Nickolay A. Khazanov, Daniel H. Hovelson, Laura E. Lamb, Marc Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William J. Edenfield, Elizabeth Claire Dees, Adedayo A. Onitilo, Gary L. Buchschacher, Alan M. Miller, Benjamin M. Parsons, Timothy R. Wassenaar, Jennifer M. Suga, Robert D. Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory A. Masters, Sachdev Thomas, Malek M. Safa, Daniel M. Anderson, Jonathan Mowers, Anna C. Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D. Bryan Johnson, Daniel R. Rhodes, Scott A. Tomlins
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1335–1349.
https://doi.org/10.1158/2767-9764.CRC-23-0036
Published: 25 July 2023
View article titled, Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Open the PDF for Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit in another window
Includes: Supplementary data
Journal Articles

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Stephanie L. Alden, Mir Lim, Chester Kao, Daniel Shu, Amit G. Singal, Anne Noonan, Paige Griffith, Marina Baretti, Won Jin Ho, Ihab Kamel, Mark Yarchoan, David Hsiehchen
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1312–1317.
https://doi.org/10.1158/2767-9764.CRC-23-0072
Published: 20 July 2023
View article titled, Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
Open the PDF for Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Th1-like CD4+ T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer

Akitoshi Yanagihara, Satoshi Yamasaki, Kosuke Hashimoto, Ryo Taguchi, Tetsuya Umesaki, Hisao Imai, Kyoichi Kaira, Hiroyuki Nitanda, Hirozo Sakaguchi, Hironori Ishida, Kunihiko Kobayashi, Katsuhisa Horimoto, Hiroshi Kagamu
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1277–1285.
https://doi.org/10.1158/2767-9764.CRC-23-0167
Published: 19 July 2023
View article titled, A Th1-like CD4<sup>+</sup> T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer
Open the PDF for A Th1-like CD4<sup>+</sup> T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Satu Mustjoki
Journal: Cancer Research Communications
Cancer Research Communications (2023) 3 (7): 1260–1276.
https://doi.org/10.1158/2767-9764.CRC-22-0514
Published: 18 July 2023
View article titled, Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
Open the PDF for Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma in another window
Includes: Supplementary data